|
PAIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.991400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.338600E-01 |
| Normal-vs-Stage2 |
3.527200E-01 |
| Normal-vs-Stage3 |
2.978400E-01 |
| Normal-vs-Stage4 |
5.778100E-02 |
| Stage1-vs-Stage2 |
7.188200E-01 |
| Stage1-vs-Stage3 |
6.617000E-01 |
| Stage1-vs-Stage4 |
1.447800E-01 |
| Stage2-vs-Stage3 |
9.726800E-01 |
| Stage2-vs-Stage4 |
5.078400E-01 |
| Stage3-vs-Stage4 |
3.763600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.068400E-01 |
| Normal-vs-AfricanAmerican |
8.098000E-01 |
| Normal-vs-Asian |
5.608600E-01 |
| Caucasian-vs-AfricanAmerican |
6.362000E-01 |
| Caucasian-vs-Asian |
7.583800E-01 |
| AfricanAmerican-vs-Asian |
8.239600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.999500E-02 |
| Normal-vs-Female |
4.472000E-01 |
| Male-vs-Female |
1.979650E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.936200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.479980E-01 |
| Normal-vs-Age(61-80Yrs) |
1.907840E-01 |
| Normal-vs-Age(81-100Yrs) |
9.266200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.977600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.202000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.314200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.558200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.624800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.763800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.425000E-01 |
| Classical-VS-Follicular |
6.681600E-03 |
| Classical-VS-Other |
8.317000E-01 |
| Classical-VS-Normal |
7.776200E-01 |
| Tall-VS-Follicular |
1.732450E-01 |
| Tall-VS-Other |
9.186800E-01 |
| Tall-VS-Normal |
6.999200E-01 |
| Follicular-VS-Other |
5.304200E-01 |
| Follicular-VS-Normal |
3.651700E-02 |
| Other-VS-Normal |
7.405000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.960100E-02 |
| Normal-vs-N1 |
5.446000E-01 |
| N0-vs-N1 |
4.142400E-01 |
|
|
